Overexpression of MMP-9 contributes to invasiveness of prostate cancer cell line LNCaP

Immunological Investigations

Volumn 40, Issue 5, 2011, Pages 447-464

  Aalinkeel, Ravikumar ^a   Nair, Bindukumar B ^a   Reynolds, Jessica L ^a   Sykes, Donald E ^a   Mahajan, Supriya D ^a   Chadha, Kailash C ^b   Schwartz, Stanley A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Cancer invasion; Metalloproteinases; Metastasis; MMP 9; Prostate cancer; Proteases; Tissue re modeling

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ENZYME INHIBITOR; GELATINASE B;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

BASEMENT MEMBRANE; CELL LINE, TUMOR; ENZYME INHIBITORS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES, ANTISENSE; PROSTATIC NEOPLASMS;

EID: 80053300966     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2011.557795     Document Type: Article

References (52)

1. Aalinkeel, R., Nair, M. P., Sufrin, G., Mahajan, S. D., Chadha, K. C., Chawda, R. P., and Schwartz S. A. (2004). Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res. 64:5311-5321. (Pubitemid 39006551)
2. Albini, A. (1998). Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol. Oncol. Res. 4:230-241. (Pubitemid 28554963)
3. Axelrod, J. H., Reich, R., and Miskin, R. (1989). Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells. Mol. Cell. Biol. 9:2133-2141. (Pubitemid 19117814)
4. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell. Biol. 2:737-744.
5. Bonfil, R. D., Reddel, R. R., Ura, H., Reich, R., Fridman, R., Harris, C. C., and Klein-Szanto, J. P. (1989). Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line. J. Natl. Cancer Inst. 81:587-594. (Pubitemid 19104489)
6. Chiarugi, V., Ruggiero, M., and Magnelli, L. (2000). Molecular polarity in endothelial cells and tumor-induced angiogenesis. Oncol. Res. 12:1-4.
7. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159. (Pubitemid 17064313)
8. Coussens, L. M., Fingleton B., and Matrisian L. M. (2002). Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 29:2387-2392. (Pubitemid 34270240)
9. Coussens, L. M., Tinkle, C. L., Hanahan, D., and Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-490.
10. Coussens, L. M., and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867. (Pubitemid 36019639)
11. Dahiya, R., Park, H. D., Cusick, J., Vessella, R. L., Fournier, G., and Narayan, P. (1994). Inhibition of tumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cis-retinoic acid. Int. J. Cancer 59:126-132. (Pubitemid 24310958)
12. Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., and Skriver, L. (1985). Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139-266.
13. Dano, K., and Reich, E. (1978). Serine enzymes released by cultured neoplastic cells. J. Exp. Med. 147:745-757. (Pubitemid 8303488)
14. Dedhar, S., Saulnier, R., Nagle, R., and Overall, C. M. (1993). Specific alterations in the expression of alpha 3 beta 1 and alpha 6 beta 4 integrins in highly invasive and metastatic variants of human prostate carcinoma cells selected by in vitro invasion through reconstituted basement membrane. Clin. Exp. Metastasis 11:391-400. (Pubitemid 23285492)
15. Egeblad, M., and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161-174. (Pubitemid 37328786)
16. Festuccia, C., Bologna, M., Vicentini, C., Tacconelli, A., Miano, R., Violini, S., and Mackay, A. R. (1996). Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells. Int. J. Cancer 69:386-393. (Pubitemid 26384108)
17. Fingleton, B., and Matrisian, L. M. (2001). Matrix metalloproteinases as targets for therapy in Kaposi sarcoma. Curr. Opin. Oncol. 13:368-373. (Pubitemid 32783415)
18. Fukumura, D., Yuan, F., Monsky, W. L., Chen, Y., and Jain, R. K. (1997). Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am. J. Pathol. 151:679-688. (Pubitemid 27385599)
19. Ghosh, C., Stein, D., Weller, D., and Iversen, P. (2000). Evaluation of antisense mechanisms of action. Meth. Enzymol. 313:135-143. (Pubitemid 29506414)
20. Giles, R. V., Spiller, D. G., Clark, R. E., and Tidd, D. M. (1999). Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA. Antisense Nucl. Acid Drug Dev. 9:213-220. (Pubitemid 29248741)
21. Gleave, M., Hsieh, J. T., Gao, C. A., Von Eschenbach, A. C., and Chung, L. W. (1991). Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res. 51:3753-3761.
22. Grondahl-Hansen, J., Lund, L. R., Ralfkiaer, E., Ottevanger, V., and Dano, K. (1988). Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J. Invest. Dermatol. 90:790-795.
23. Hoosein, N. M., Boyd, D. D., Hollas, W. J., Mazar, A., Henkin, J., and Chung, L. W. (1991). Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. Cancer Commun. 3:255-264.
24. Huang, S., Van Arsdall, M., Tedjarati, S., McCarty, M., Wu, W., Langley, R., and Fidler, I. J. (2002). Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J. Natl. Cancer Inst. 94:1134-1142. (Pubitemid 34919050)
25. Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., and Uehira, M. (1999). Experimental metastasis is suppressed in MMP-9-deficient mice. Clin. Exp. Metastasis 17:177-181. (Pubitemid 29335445)
26. Iversen P. L. (2001). Phosphorodiamidate morpholino oligomers: Favorable properties for sequence-specific gene inactivation. Curr. Opin. Mol. Ther. 3:235-238. (Pubitemid 32624571)
27. Kim, J., Yu, W., Kovalski, K., and Ossowski, L. (1998). Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94:353-362. (Pubitemid 28376079)
28. Kondraganti, S., Mohanam, S., Chintala, S. K., Kin, Y., Jasti, S. L., Nirmala, C., Lakka, S. S., Adachi, Y., Kyritsis, A. P., Ali-Osman, F., Sawaya, R., Fuller, G. N., and Rao, J. S. (2000). Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res. 60:6851-6855. (Pubitemid 32059151)
29. Lakka, S. S., Jasti, S. L., Gondi, C., Boyd, D., Chandrasekar, N., Dinh, D. H., Olivero, W. C., Gujrati, M., and Rao, J. S. (2002a). Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21:5601-5608. (Pubitemid 34983550)
30. Lakka, S. S., Rajan, M., Gondi, C., Yanamandra, N., Chandrasekar, N., Jasti, S. L., Adachi, Y., Siddique, K., Gujrati, M., Olivero, W., Dinh, D. H., Kouraklis, G., Kyritsis, A. P., and Rao, J. S. (2002b). Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 21:8011-8019. (Pubitemid 35434187)
31. + channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am. J. Pathol. 150:1213-1221. (Pubitemid 27152640)
32. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336. (Pubitemid 121001258)
33. Lokeshwar, B. L., Selzer, M. G., Block, N. L., and Gunja-Smith, Z. (1993). Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: Reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res. 53:4493-4498. (Pubitemid 23304370)
34. Nelson, A. R., Fingleton, B., Rothenberg, M. L., and Matrisian, L. M. (2000). Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18:1135-1149. (Pubitemid 30123793)
35. Ossowski, L., Biegel, D., and Reich, E. (1979). Mammary plasminogen activator: Correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 16:929-940. (Pubitemid 9161343)
36. Ossowski, L., and Reich, E. (1983). Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611-619. (Pubitemid 14168365)
37. Paget, S. (1989). The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 8:98-101.
38. Pepper, M. S., Vassalli, J. D., Montesano, R., and Orci, L. (1987). Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J. Cell. Biol. 105:2535-2541. (Pubitemid 18017683)
39. Rembrink, K., Romijn, J. C., Van Der Kwast, T. H., Rubben, H., and Schroder, F. H. (1997). Orthotopic implantation of human prostate cancer cell lines: A clinically relevant animal model for metastatic prostate cancer. Prostate 31:168-174. (Pubitemid 27225200)
40. Rhee, J. S., and Coussens, L. M. (2002). RECKing MMP function: Implications for cancer development. Trends Cell. Biol. 12:209-211. (Pubitemid 34327606)
41. Sato, N., Gleave, M. E., Bruchovsky, N., Rennie, P. S., Beraldi, E., and Sullivan, L. D. (1997). A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res. 57:1584-1589. (Pubitemid 27175579)
42. Stephenson, R. A., Dinney, C. P., Gohji, K., Ordonez, N. G., Killion, J. J., and Fidler, I. J. (1992). Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J. Natl. Cancer Inst. 84:951-957.
43. Summerton J. (1999). Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim. Biophys. Acta 1489:141-158.
44. Summerton J., and Weller D. (1997). Morpholino antisense oligomers: Design, preparation, and properties. Antisense Nucl. Acid Drug Dev. 7:187-195. (Pubitemid 27323077)
45. Unkeless J., Dano K., Kellerman G. M., and Reich E. (1974). Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator. J. Biol. Chem. 249:4295-4305.
46. Van Kempen L. C., and Coussens L. M. (2002). MMP9 potentiates pulmonary metastasis formation. Cancer Cell 2:251-252. (Pubitemid 41043957)
47. Van Kempen L. C., Rhee J. S., Dehne K., Lee J., Edwards D. R., and Coussens L. M. (2002). Epithelial carcinogenesis: Dynamic interplay between neoplastic cells and their microenvironment. Differentiation 70:610-623. (Pubitemid 36194325)
48. Werb Z. (1997). ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91:439-442. (Pubitemid 27508232)
49. Woessner J. F., Jr. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:2145-2154. (Pubitemid 21905847)
50. Wood M., Fudge K., Mohler J. L., Frost A. R., Garcia F., Wang M., and Stearns M. E. (1997). In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin. Exp. Metastasis 15:246-258. (Pubitemid 27240355)
51. Xu D., McKee C. M., Cao Y., Ding Y., Kessler B. M., and Muschel R. J. (2010). Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. Cancer Res. 70:6988-6998.
52. Xu D., Suenaga N., Edelmann M. J., Fridman R., Muschel R. J., and Kessler B. M. (2008). Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol. Cell Proteomics 7:2215-2228.